Table 9 Adverse events for prostatic artery embolization (PAE) vs transurethral resection of the prostate (TURP) classified by Clavien-Dindo Grade
Adverse Event | Abt et al. 2021 [19] | Carnevale et al. 2016 [20] | Gao et al. 2014 [21] | Insausti et al. 2020 [22] | Radwan et al. 2020 [23] | Ray et al. 2018 [24] | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PAE n (%) | TURP n (%) | Original PAE n (%) | PErFecTED PAE n (%) | TURP n (%) | PAE n (%) | TURP n (%) | PAE n (%) | TURP n (%) | PAE n (%) | M-TURP n (%) | B-TURP n (%) | PAE n (%) | TURP n (%) | |
Clavien Grade I | 22/34 (66%) | 30/47 (64%) | NR | NR | NR | 20/54 (37.0%) | 8/53 (15.1%) | 6/23 (26.7%) | 12/22 (53.2%) | NR | NR | NR | NR | NR |
Clavien Grade II | 8/34 (24%) | 10/47 (22%) | NR | NR | NR | 2/54 (3.7%) | 5/48 (10.4%) | 17/23 (73.3%) | 10/22 (44.7%) | NR | NR | NR | NR | NR |
Clavien grade ≥ III | 4/34 (11.8%) | 10/47 (21.3%) | 0/15 (0%) | 0/15 (0%) | 2/15 (13.3%) | 8/54 (14.8%) | 4/53 (7.5%) | 0/23 (0%) | 1/22 (4.5%) | NR | NR | NR | NR | NR |